XML 32 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Note 9 - Equity Compensation
12 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
NOTE
9
EQUITY COMPENSATION
 
In
November 2019,
the Company's shareholders approved the
2019
Omnibus Award Plan (
“2019
Omnibus Plan”). The purpose of the
2019
Omnibus Plan is to provide a means through which the Company
may
attract and retain key personnel and to provide a means by which directors, officers, and employees can acquire and maintain an equity interest in the Company. The
2019
Omnibus Plan replaced the
2012
Stock Incentive Plan (
“2012
Stock Plan”). The number of shares of common stock authorized for issuance under the
2019
Omnibus Plan is
2,650,000
which were combined with the remaining shares available under the
2012
Stock Plan. The number of shares reserved for issuance under the
2019
Omnibus Plan is
3,907,749
shares all of which are available for future grant or award as of
June 30, 2020.
The Plan contains a fungible share ratio that consumes
2.5
available shares for every full value share awarded by the Company as stock compensation. The
2019
Omnibus Plan allows for the grant of non-qualified stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance stock units and other stock-based awards.
 
The Company has made time-based and performance-based stock option awards. Options generally have a
three
- or
four
-year ratable vesting period beginning
one
year after the date of grant. The maximum exercise period of service-based and performance-based stock options granted under the Plan is
ten
years. 
 
Inducement stock option agreements are granted by the Company to attract and retain key executives. Inducement stock options are separately registered securities and are
not
part of the
2019
Omnibus Plan. Some options granted have a
three
-year ratable vesting period whereas other options vest upon specific performance of the Company's stock. All Inducement stock options have a term of
ten
years only if the employee is employed for
three
years from the date of grant. In fiscal
2020,
280,000
Inducement stock options were granted.
 
Restricted Stock Units (RSUs) ratably vest over a
three
- or
four
-year period beginning
one
year after the date of award. Performance Stock Units (PSUs) vest if the Company meets certain financial metrics over a
three
-year period.
 
Stock Warrants
 
The Company has outstanding
200,000
fully exercisable stock warrants with an exercise price of
$9.95
as of
June 30, 2020.
As of
June 30, 2020,
the warrants had a remaining contractual life of
1.6
years. The fair value of the warrants on the date of grant was estimated using the Black-Scholes option pricing model. The following table summarizes the weighted-average assumptions used in the Black-Scholes option price model to value the warrants in the period indicated:
 
   
February 21,
2017
 
Dividend yield
   
2.01
%
Expected volatility
   
39
%
Risk-free interest rate
   
1.80
%
Expected life (in years)
   
4.5
 
Fair value per share
  $
2.87
 
 
Stock Options
 
The fair value of each option on the date of grant was estimated using the Black-Scholes option pricing model. The following table summarizes the weighted-average assumptions used in the Black-Scholes option pricing model to value the stock options granted in the periods indicated:
 
   
2020
   
2019
 
Dividend yield
 
 
4.7
%
   
4.6
%
Expected volatility
 
 
43
%
   
42
%
Risk-free interest rate
 
 
1.4
%
   
2.8
%
Expected life (in years)
 
 
6.0
     
4.9
 
Fair value per share
 
$
1.22
    $
1.48
 
 
The Company calculates stock option expense using the Black-Scholes model. Stock option expense is recorded on a straight-line basis, or sooner if the grantee is retirement eligible as defined in the Plan, net of forfeitures. The forfeiture rate is based on historical rates and reduces the compensation expense recognized. The expected volatility of the Company's stock was calculated based upon the historic monthly fluctuation in stock price for a period approximating the expected life of option grants. The risk-free interest rate is the rate of a
five
-year Treasury security at constant, fixed maturity on the approximate date of the stock option grant. The expected life of outstanding options is determined to be less than the contractual term for a period equal to the aggregate group of option holders' estimated weighted average time within which options will be exercised. It is the Company's policy that when stock options are exercised, new common shares shall be issued.    
 
The Company recorded
$0.4
million and
$0.9
million of expense related to stock options in fiscal years
2020
and
2019,
respectively.
 
A summary of stock option activity as of
June 30, 2020
and changes during the period from
July 1, 2019
through
June 30, 2020
are as follows:
 
   
Shares
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Term
(in years)
   
Aggregate
Intrinsic
Value
 
Outstanding at June 30, 2019
   
2,749,626
    $
7.23
     
6.8
    $
23,500
 
Granted
   
735,429
    $
4.51
     
 
     
 
 
Exercised
   
(143,766
)   $
5.57
     
 
     
 
 
Forfeited
   
(889,351
)   $
7.69
     
 
     
 
 
Expired
   
(169,000
)   $
8.24
     
 
     
 
 
Outstanding at June 30, 2020
   
2,282,938
    $
6.20
     
7.1
    $
2,731,949
 
Exercisable at June 30, 2020
   
1,017,148
    $
8.35
     
5.1
    $
100,719
 
Vested and expected to vest at June 30, 2020
   
2,206,744
    $
6.26
     
7.0
    $
2,574,232
 
 
The aggregate intrinsic value of options exercised during the years ended
June 30, 2020
and
June 30, 2019
was
$0.1
million and
$0,
respectively. The Company received
$0.6
million of proceeds from stock options exercises in fiscal
2020.
There were
no
exercises of stock options in fiscal
2019.
 
As of
June 30, 2020,
there was
$1.0
million of unrecognized compensation cost, net of forfeitures, related to stock options, which is expected to be recognized over a weighted-average remaining period of
2.4
years.
 
For fiscal year
2020,
the Company recognized a current income tax benefit of
$43,000
for tax deductions related to equity compensation. A discrete tax expense of
$0.4
million was recognized to reduce deferred tax assets for cancelled awards and detriments in excess of the tax deductions.
 
For fiscal year
2019,
the Company recognized a current income tax benefit of
$0.1
million for tax deductions related to equity compensation. A discrete tax expense of
$0.3
million was recognized to reduce deferred tax assets for cancelled awards and detriments in excess of the tax deductions.
 
Restricted Stock Units
 
A total of
81,917
RSUs with a weighted average fair value of
$3.83
per share were awarded to employees during fiscal
2020.
There were
no
RSUs awarded to employees during fiscal
2019.
RSUs awarded during fiscal
2020
have a
three
-year ratable vesting period. The Company determined the fair value of the awards based on the closing price of the Company stock on the date the RSUs were awarded. The unvested RSUs are non-voting, but accrue cash dividends at the same per share rate as those cash dividends declared and paid on LSI's common stock. Dividends on RSUs in the amount of
$16,931
and
$16,848
were accrued as of
June 30, 2020
and
2019,
respectively. Accrued dividends are paid to the holder upon vesting of the RSUs and issuance of shares.
 
The Company recorded
$0.1
million of expense related to RSUs during fiscal year
2020.
 
A summary of outstanding and unvested RSU activity as of
June 30, 2020
and changes during the period from
July 1, 2019
through
June 30, 2020
are as follows:
 
   
Shares
   
Weighted-
Average Grant
Date Fair Value
 
Unvested at June 30, 2019
   
33,042
    $
7.72
 
Granted
   
81,917
    $
3.83
 
Vested
   
(21,126
)   $
8.06
 
Forfeited
   
(21,013
)   $
5.00
 
Unvested at June 30, 2020
   
72,820
    $
4.03
 
 
As of
June 30, 2020,
there was
$0.2
million of unrecognized compensation cost, net of forfeitures, related to RSUs, which is expected to be recognized over a weighted-average remaining period of
2.1
years. The total fair value of RSUs that became fully vested during fiscal
2020
was
$0.1
million.
 
Performance
Stock Units
 
A total of
199,310
PSUs with a weighted average fair value of
$3.83
per share were awarded to employees during fiscal
2020.
The Company determined the fair value of the awards based on the closing price of the Company stock on the date the PSUs were awarded. The PSUs are non-voting, but accrue cash dividends at the same per share rate as those cash dividends declared and paid on LSI's common stock. Dividends on PSUs in the amount of
$46,865
and
$11,310
were accrued as of
June 30, 2020
and
2019,
respectively. Accrued dividends are paid to the holder upon vesting of the PSUs and issuance of shares.
 
The Company recorded
$0.1
million and
$0.1
million of expense related to PSUs during fiscal years
2020
and
2019,
respectively.
 
A summary of outstanding and unvested PSU activity as of
June 30, 2020
and changes during the period from
July 1, 2019
through
June 30, 2020
are as follows:
 
   
Shares
   
Weighted-
Average Grant
Date Fair Value
 
Unvested at June 30, 2019
   
56,550
    $
4.94
 
Granted
   
199,310
    $
3.83
 
Vested
   
-
    $
-
 
Forfeited
   
(48,886
)   $
4.49
 
Unvested at June 30, 2020
   
206,974
    $
3.98
 
 
As of
June 30, 2020,
there was
$0.4
million of unrecognized compensation cost, net of forfeitures, related to PSUs, which is expected to be recognized over a weighted-average remaining period of
2.1
years.
 
Director and Employee Stock Compensation Awards
 
The Company awarded a total of
71,581
and
104,020
common shares as stock compensation awards in fiscal years
2020
and
2019,
respectively. These common shares were valued at their approximate
$0.3
million and
$0.4
million fair market values based on their stock price at dates of issuance multiplied by the number of common shares awarded, respectively, pursuant to the compensation programs for non-employee directors who receive a portion of their compensation as an award of Company stock and for employees who received a nominal recognition award in the form of Company stock. Stock compensation awards are made in the form of newly issued common shares of the Company.
 
Deferred Compensation Plan
 
 
The Company has a non-qualified deferred compensation plan providing for both Company contributions and participant deferrals of compensation. This plan is fully funded in a Rabbi Trust. All plan investments are in common shares of the Company. As of
June 30, 2020,
there were
26
participants, all with fully vested account balances. A total of
180,264
common shares with a cost of
$1.1
million, and
208,965
common shares with a cost of
$1.5
million were held in the plan as of
June 
30,
2020
and
2019,
respectively, and, accordingly, have been recorded as treasury shares.
 
The change in the number of shares held by this plan is the net result of purchases of shares on the open stock market or newly issued shares as compensation deferred into the plan offset by distributions to terminated employees. The Company issued
85,560
and
74,721
new common shares for purposes of the non-qualified deferred compensation plan during fiscal
2020
and during fiscal
2019,
respectively.
 
The Company's non-qualified deferred compensation is
no
longer funded by purchases in the open market of LSI stock as of
September 30, 2017.
This plan is now solely funded by newly issued shares that are authorized from the Plan.